Insight Guide
Achieving consistency in process development of mRNA therapeutics
Selecting raw materials is one of the earliest steps in the development of mRNA vaccines and therapeutics. The materials you choose have the potential to influence your process development and drug quality.
In this guidebook, created in collaboration with BioPharma Dive, we share insights into:
- The role raw materials play in supporting consistency in process development
- The importance of quality control and the downstream ramifications of choosing suboptimal materials
- How drug developers can evaluate materials and suppliers to find solutions that meet their needs
